Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
Cascadian Therapeutics
is defunct.
Bought by Seattle Genetics, Feb 2018, $614m stock
------------------
If you believe any of this information is incorrect, please
let us know
.